We are live on ! Find out more
AIM

Alambic Investment Management Portfolio holdings

AUM $9.12M
1-Year Est. Return 34.55%
This Fund
S&P 500
This Quarter Est. Return
+10.58%
1 Year Est. Return
+34.55%
3 Year Est. Return
+47.56%
5 Year Est. Return
+107.87%
10 Year Est. Return
–
AUM
$9.12M
AUM Growth
-$30.8M
Cap. Flow
-$30.4M
Cap. Flow %
-333.82%
Top 10 Hldgs %
37.71%
Holding
181
New
18
Increased
8
Reduced
44
Closed
108

Top Buys

Rank Stock Value
1
STSA
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
+$416K
2
CSGP icon
CoStar Group
CSGP
+$207K
3
DNOW icon
DNOW Inc
DNOW
+$192K
4
PLAB icon
Photronics
PLAB
+$131K
5
GYRE icon
Gyre Therapeutics
GYRE
+$92.2K

Top Sells

Rank Stock Value
1
CLCT
Collectors Universe
CLCT
+$605K
2
CTVA icon
Corteva
CTVA
+$581K
3
MTRN icon
Materion
MTRN
+$581K
4
NPTN
NEOPHOTONICS CORP
NPTN
+$556K
5
SPTN
SpartanNash
SPTN
+$543K

Sector Composition

Rank Sector Weight
1 Technology 36.92%
2 Healthcare 34.13%
3 Industrials 7.29%
4 Energy 5.56%
5 Consumer Staples 4.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SBBP
26
DELISTED
Strongbridge Biopharma plc.
SBBP
$114K 1.25%
54,164
-7,200
-12% -$24.3K
DZSI
27
DELISTED
DZS Inc. Common Stock
DZSI
$111K 1.22%
11,879
-800
-6% -$8.03K
LUNA
28
DELISTED
Luna Innovations Incorporated
LUNA
$111K 1.22%
18,513
-82,041
-82% -$486K
CLNE icon
29
Clean Energy Fuels
CLNE
$359M
$110K 1.21%
44,300
-15,100
-25% -$39.3K
STIM icon
30
Neuronetics
STIM
$224M
$107K 1.17%
22,026
-39,810
-64% -$151K
KZR
31
DELISTED
Kezar Life Sciences
KZR
$102K 1.12%
2,114
-48
-2% -$2.3K
FIT
32
DELISTED
Fitbit, Inc. Class A common stock
FIT
$102K 1.12%
14,607
– –
ASYS icon
33
Amtech Systems
ASYS
$264M
$96K 1.05%
19,723
-32,935
-63% -$170K
GSIT icon
34
GSI Technology
GSIT
$219M
$87K 0.95%
15,502
-30,186
-66% -$192K
ERII icon
35
Energy Recovery
ERII
$397M
$86K 0.94%
+10,500
New +$84.2K
RVP icon
36
Retractable Technologies
RVP
$21.9M
$86K 0.94%
12,850
-24,350
-65% -$193K
IA
37
Innovative Solutions & Support
IA
$370M
$84K 0.92%
12,212
-9,071
-43% -$56.9K
MCHX icon
38
Marchex
MCHX
$81.6M
$81K 0.89%
38,126
-5,914
-13% -$10.4K
STSA
39
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$81K 0.89%
+20,711
New +$416K
RMNI icon
40
Rimini Street
RMNI
$527M
$78K 0.86%
24,089
+12,170
+102% +$55.9K
IVAC
41
DELISTED
Intevac Inc
IVAC
$78K 0.86%
14,191
-25,075
-64% -$145K
NPTN
42
DELISTED
NEOPHOTONICS CORP
NPTN
$78K 0.86%
12,840
-72,816
-85% -$556K
GYRE icon
43
Gyre Therapeutics
GYRE
$699M
$76K 0.83%
+2,357
New +$92.2K
HBIO icon
44
Harvard Bioscience
HBIO
$36.1M
$76K 0.83%
2,540
-1,366
-35% -$45.9K
ORN icon
45
Orion Group Holdings
ORN
$375M
$71K 0.78%
25,828
-9,677
-27% -$27.6K
ATEN icon
46
A10 Networks
ATEN
$1.87B
$70K 0.77%
+11,000
New +$84.3K
CVGI icon
47
Commercial Vehicle Group
CVGI
$127M
$70K 0.77%
10,735
-14,100
-57% -$54.4K
RVLP
48
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
$68K 0.75%
12,516
-35,456
-74% -$204K
TNAV
49
DELISTED
Telenav Inc.
TNAV
$67K 0.73%
18,553
-79,847
-81% -$388K
MRAM icon
50
Everspin Technologies
MRAM
$403M
$65K 0.71%
11,433
-5,671
-33% -$36.1K
1
2
3 4 5

Similar funds

SC
Spindletop Capital Chappaqua, New York $8.71M AUM
KPC
Karst Peak Capital Hong Kong $8.61M AUM 270.01% 1-Year Est. Return
CIM
Castleton Investment Management Stamford, Connecticut $10M AUM 20.83% 1-Year Est. Return
BCIM
Burford Capital Investment Management Chicago, Illinois $6.17M AUM 38.81% 1-Year Est. Return
MVUM
Matrix VIII US Management Cambridge, Massachusetts $6.07M AUM 40.92% 1-Year Est. Return
NC
Numen Capital London, United Kingdom $13.5M AUM 47.6% 1-Year Est. Return
FWCM
First Western Capital Management Los Angeles, California $4.71M AUM 11.17% 1-Year Est. Return
FP
FFL Partners San Francisco, California $16.1M AUM 46.91% 1-Year Est. Return

Alambic Investment Management's Q3 2020 Portfolio in Review

As of Q3 2020, Alambic Investment Management held 181 positions worth $9.12M, down 77% from $39.9M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Alambic Investment Management withdrew a net $30.4M in Q3 2020, closing 108 positions and reducing 44 holdings. Its most notable exit was Collectors Universe, an estimated $605K position sold in full.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 28% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Alambic Investment Management opened a new position in Satsuma Pharmaceuticals, Inc. Common Stock worth $81K.

  • Alambic Investment Management's largest Q3 2020 buy was Satsuma Pharmaceuticals, Inc. Common Stock: 20,711 shares worth $81K.
  • Alambic Investment Management added most to Rimini Street in Q3 2020, an estimated $55.9K increase.
  • Alambic Investment Management's biggest Q3 2020 reduction was NEOPHOTONICS CORP, cutting an estimated $556K.
  • Alambic Investment Management fully exited Collectors Universe in Q3 2020, selling an estimated $605K.
  • Alambic Investment Management's ten largest holdings make up 38% of its $9.12M portfolio in Q3 2020.
  • Alambic Investment Management opened 18 new positions and closed 108 in Q3 2020.
  • Alambic Investment Management's portfolio value fell 77% quarter-over-quarter to $9.12M.

Based on Alambic Investment Management's 13F filing for Q3 2020, filed 13 Nov 2020.